---  
layout: startup_page  
title: "NewLimit"  
id: "newlimit.com"  
permalink: "/newlimitnewlimit.com05062025/"  
website: "https://www.newlimit.com/"  
funding_round: "Series B"  
funding_amount: "$130M"  
investors: "Kleiner Perkins, Nat Friedman, Daniel Gross, Khosla Ventures, Founders Fund, Dimension Capital, Elad Gil, Garry Tan, Patrick Collison, and others"  
about: "NewLimit aims to increase how long people can live a healthy life by genetically programming their cells. The company is developing treatments that can restore youthful characteristics to aged cells, specifically focusing on reprogramming liver cells. They are employing an AI model to accelerate the development and testing of new anti-aging medicines."  
markets: "Biotech, Healthtech, Drug Discovery"  
hq: "South San Francisco, California, United States"  
founded_year: "2021"  
linkedin: "https://www.linkedin.com/company/newlimit"  
twitter: "https://twitter.com/newlimit"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/newlimit/company_financials"  
pitchbook: "https://pitchbook.com/profiles/company/489108-07"  

date_display: "06-May-2025"  
date: "2025-05-06"

# SEO Optimization  
meta_title: "NewLimit - Series B Funding ($130M)"  
meta_description: "NewLimit, NewLimit aims to increase how long people can live a healthy life by genetically programming their cells. The company is developing treatments that ca..."  
meta_keywords: "NewLimit, Biotech, Healthtech, Drug Discovery, Series B funding"  
canonical_url: "https://startup.projectstartups.com/newlimitnewlimit.com05062025/"  
---